Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2007
06/21/2007US20070142474 Jasmonate derivative compounds, pharmaceuticals compounds and methods of use thereof
06/21/2007US20070142473 Dosage forms and methods using ethacrynic acid
06/21/2007US20070142472 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids
06/21/2007US20070142471 Sulfonamides
06/21/2007US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate
06/21/2007US20070142469 Method of using beta-hydroxy-beta-methylbutyrate
06/21/2007US20070142468 Compositions containing prodrugs of florfenicol and methods of use
06/21/2007US20070142467 3-alkylaryl aspartate compounds and their use for selective enhancement of synaptic transmission
06/21/2007US20070142466 Photoreactive compounds and compositions
06/21/2007US20070142465 Macrophage activation inhibitor
06/21/2007US20070142464 Nonsteroidal progesterone receptor modulators
06/21/2007US20070142462 Method of Treating Cancer
06/21/2007US20070142461 Cyclic alkyl substituted glycolides and polylactides therefrom
06/21/2007US20070142460 Compounds, compositions and methods
06/21/2007US20070142459 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
06/21/2007US20070142458 For therapy of allergic or inflammatory disorders of the eye and nose
06/21/2007US20070142457 Crystalline forms of docetaxel and processes for their preparation
06/21/2007US20070142456 Method for inhibiting cancer development by fatty acid synthase inhibitors
06/21/2007US20070142455 N-acyl-n'-benzyl-alkylendiamino derivatives
06/21/2007US20070142454 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase i
06/21/2007US20070142453 1-Alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment of alzheimer's disease and related conditions
06/21/2007US20070142452 Fused pyrrole derivatives
06/21/2007US20070142451 Crystalline form of carvedilol hydrobromide, which is the hydrobromide salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol, and/or other carvedilol solvates thereof for treatment of hypertension, congestive heart failure, and angina
06/21/2007US20070142450 Novel urea derivatives and their medical use
06/21/2007US20070142449 Angiogenesis inhibitors
06/21/2007US20070142448 such as 4-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxyl]-N,N,2-trimethyl-1H-benzimidazole -6-carboxamide, used as acid pump antagonists for the treatment of gastrointestinal disorders
06/21/2007US20070142447 Veterinary composition comprising an arylpyrazole and a nitroenamine with enhanced antiparasitic activity
06/21/2007US20070142446 (Indol-3-yl) heterocycle derivatives as a agonists of the cannabinoid cb1 receptor
06/21/2007US20070142445 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives
06/21/2007US20070142443 Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives
06/21/2007US20070142442 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/21/2007US20070142441 2-Cyano-4'-[3-(propane-2-sulfonylamino)-thiophen-2-yl]-biphenyl-4-carboxylic acid; schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, Parkinson's disease, or depression; antipsychotics, antidepressants
06/21/2007US20070142440 Pyridinamide derivatives as kinase inhibitors
06/21/2007US20070142438 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia
06/21/2007US20070142437 Chemical compounds
06/21/2007US20070142436 New salt and polymorph of a DPP-IV inhibitor
06/21/2007US20070142435 [4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase
06/21/2007US20070142434 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
06/21/2007US20070142433 Angiogenesis-affecting compounds and methods of use thereof
06/21/2007US20070142432 4-((5-Ethoxy-2-fluoro-3-isopropoxyphenyl)(4-p-tolyl-1H-imidazol-2-yl)methylamino)benzimidazole bis(trifluoroacetic acid salt); leukotriene A4 hydrolase inhibitors; antiinflammatory agents; atherosclerosis; angina pectoris; myocardium infarction; antiischemic aagents; angioplasty; stents; bypass; grafting
06/21/2007US20070142431 Quinoline 4-carboxamide derivatives and their use as neurokinin 3 (nk-3) receptor antagonists
06/21/2007US20070142430 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof
06/21/2007US20070142429 Isoquinoline compounds
06/21/2007US20070142428 isoquinoline-3-carboxylic acid{(S)-1-azabicyclo[2.2.2]oct-3-yl}-amide; alpha 7 nicotinic acetylcholine receptor agonists; psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerative disorders such as senile dementia, Alzheimer's disease; attention deficit disorders
06/21/2007US20070142427 Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
06/21/2007US20070142426 Method of cancer screening; method of cancer treatment; and method of diabetes treatment
06/21/2007US20070142425 Use of CCI-779 as an antineoplastic agent
06/21/2007US20070142424 Process for producing tacrolimus (FK-506) using vegetable oil as sole source of carbon
06/21/2007US20070142423 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
06/21/2007US20070142422 Control of CCI-779 dosage form stability through control of drug substance impurities
06/21/2007US20070142421 Pharmaceutical Composition
06/21/2007US20070142420 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
06/21/2007US20070142419 Thienyl Compounds
06/21/2007US20070142418 Reacting 4-(Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-5-hydroxy-pyrimidine (FPP-OH) with 2,2,6,6-tetramethylpiperidine-1-oxyl (Tempo) in the presence of a co-oxidant NaClO to form 4-(Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-5-formyl-pyrimidine (FPP CHO) intermediate
06/21/2007US20070142417 Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor
06/21/2007US20070142416 Pyrimidinyl amide compounds with inhibit leukocyte adhesion mediated by VLA-4
06/21/2007US20070142415 Heteroarylpyrrolopyridinones active as kinase inhibitors
06/21/2007US20070142414 N-substituted pyrrolopyridinones active as kinase inhibitors
06/21/2007US20070142413 Pyrazole derivatives as inhibitors of receptor tyrosone kinases
06/21/2007US20070142412 Crystalline form of 2-{4-['3-(4-chloro-2-fluorophenyl)-4-pyrimidin-4-yl-1h-pyrazol-5-yl]piperidin-1-yl}-2-oxoethanol
06/21/2007US20070142411 Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disorders
06/21/2007US20070142409 3-Substituted-4-pyrimidone derivatives
06/21/2007US20070142408 Compositions and methods for inhibiting TGF-Beta
06/21/2007US20070142407 Benzo (1,2,5) thiadiazole als crf-antagonisten
06/21/2007US20070142406 Method of cancer screening; method of cancer treatment; and method of diabetes treatment
06/21/2007US20070142405 Bicyclic heterocyclic p-38 kinase inhibitors
06/21/2007US20070142404 6-(2,6-Dichlorophenyl)-triazolopyrimidines, methods for the production thereof, use thereof for controlling pathogenic fungi, and agents containing the same
06/21/2007US20070142403 Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein
06/21/2007US20070142402 Kinase Inhibitors And Their Uses
06/21/2007US20070142401 Indolyl-pyrroledione derivatives for the treatment of neurological and vascular disorders related to beta-amyloid generation and/or aggregation
06/21/2007US20070142400 Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/21/2007US20070142399 Dual function drugs and uses thereof
06/21/2007US20070142398 Tetracyclic 3-substituted indoles having serotonin receptor affinity
06/21/2007US20070142397 Phenypiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
06/21/2007US20070142396 Treatment of pain with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H)-quinolone or salt thereof
06/21/2007US20070142395 Treatment of sexual dysfunction with 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2(1H)-quinolone or salt thereof
06/21/2007US20070142394 Substituted aniline derivatives useful as histamine H3 antagonists
06/21/2007US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/21/2007US20070142392 Uses of rifamycins
06/21/2007US20070142391 Piperazine-2-carboxamide derivatives
06/21/2007US20070142390 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors
06/21/2007US20070142389 Piperidine derivatives
06/21/2007US20070142388 Inhibitors of Akt activity
06/21/2007US20070142387 Process for producing folic acid derivatives
06/21/2007US20070142386 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
06/21/2007US20070142385 Treatment of length dependent neuropathy
06/21/2007US20070142384 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
06/21/2007US20070142383 Use of these dipeptidylpeptidase-IV inhibitors; treating type I and II diabetes mellitus, arthritis, obesity, allograft transplantation, or calcitonin-induced osteoporosis; 2-amino-imidazo[4,5-d]pyridazine-4,7-diones
06/21/2007US20070142382 4-Amino-8-(2-fluoro-6-methoxy-phenyl)-N-propylcinnoline-3-carboxamide and salts; for treatment or prophylaxis of anxiety disorders, cognitive disorders, and/or mood disorders.
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142380 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
06/21/2007US20070142379 Cyclohexyl derivatives as selective estrogen receptor modulators
06/21/2007US20070142378 Method of treating restless legs syndrome and/or periodic limb movement disorder with (2s,3s) 2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol
06/21/2007US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives
06/21/2007US20070142376 Control of intraocular pressure using alk5 modulation agents
06/21/2007US20070142375 Pyrrolidine derivatives as factor xa inhibitors
06/21/2007US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
06/21/2007US20070142373 Quinoline derivatives as phosphodiesterase inhibitors
06/21/2007US20070142372 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis
06/21/2007US20070142371 Anti-Cytokine Heterocyclic Compounds
1 ... 3701 3702 3703 3704 3705 3706 3707 3708 3709 3710 3711 3712 3713 3714 3715 3716 3717 3718 3719 3720 3721 ... 7860